Oncorus, Inc.
ONCR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $55 | $45 | $27 | $24 |
| G&A Expenses | $22 | $20 | $10 | $7 |
| SG&A Expenses | $22 | $20 | $10 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | -$0 |
| Operating Expenses | $77 | $65 | $37 | $31 |
| Operating Income | -$77 | -$65 | -$37 | -$31 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | $0 | -$11 | $0 |
| Pre-Tax Income | -$77 | -$65 | -$48 | -$31 |
| Tax Expense | $1 | -$0 | -$2 | -$1 |
| Net Income | -$78 | -$65 | -$47 | -$30 |
| % Margin | – | – | – | – |
| EPS | -3.02 | -2.56 | -7.69 | -2.42 |
| % Growth | -18% | 66.7% | -217.8% | – |
| EPS Diluted | -3.02 | -2.56 | -7.69 | -2.42 |
| Weighted Avg Shares Out | 26 | 25 | 6 | 13 |
| Weighted Avg Shares Out Dil | 26 | 25 | 6 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $1 |
| Interest Expense | $2 | $0 | $0 | $0 |
| Depreciation & Amortization | $4 | $2 | $1 | $1 |
| EBITDA | -$72 | -$63 | -$37 | -$30 |
| % Margin | – | – | – | – |